Skip to content

    KESTRA MEDICAL TECHNOLOGIES, LTD.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $12.78M
    $14.71M
    $15.09M
    $17.23M
    $19.37M
    +51.5%
    $22.57M
    +53.4%
    $24.55M
    +62.7%
    $28.64M
    +66.2%
    Strengthening
    Operating Profit
    -$18.43M
    -$19.13M
    -$20.60M
    -$48.21M
    -$28.88M
    -56.7%
    -$31.75M
    -66.0%
    -$34.77M
    -68.8%
    -$39.34M
    +18.4%
    Weakening
    Net Profit
    -$19.88M
    -$20.37M
    -$21.51M
    -$52.05M
    -$25.83M
    -29.9%
    -$32.78M
    -61.0%
    -$34.17M
    -58.8%
    -$38.84M
    +25.4%
    Weakening
    EPS
    $-1.12
    $-1.19
    $-1.25
    $-0.50
    +55.4%
    $-0.64
    +46.2%
    $-0.61
    +51.2%
    Strengthening
    Other Income
    Interest
    $1.87M
    $2.32M
    $1.78M
    $1.76M
    $1.91M
    +2.0%
    $1.90M
    -18.0%
    $1.89M
    +5.9%
    $1.84M
    +4.8%
    Stable
    Depreciation
    Profit before Tax
    -$20.32M
    -$20.61M
    -$21.74M
    -$51.01M
    -$25.79M
    -27.0%
    -$32.75M
    -58.9%
    -$34.13M
    -57.0%
    -$38.64M
    +24.2%
    Weakening
    MarginsOPM
    -144.2%
    -130.1%
    -136.5%
    -279.8%
    -149.1%
    -3.4%
    -140.7%
    -8.2%
    -141.6%
    -3.7%
    -137.4%
    +50.9%
    Strengthening
    Tax
    -0.0%
    -0.0%
    -0.1%
    -0.2%
    -0.1%
    -333.3%
    -0.1%
    -150.0%
    -0.1%
    -25.0%
    -0.5%
    -150.0%
    Weakening
    ReturnsROIC
    3.4%
    3.4%
    3.6%
    8.8%
    4.4%
    +29.9%
    5.5%
    +61.0%
    5.8%
    +58.8%
    6.5%
    -25.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY24FY25FY26
    AssetsCash & Equivalents$8.25M$237.59M$99.71M
    Short-Term Investments
    Total Current Assets$14.91M$255.33M$222.36M
    Net PP&E$28.39M$36.91M$62.45M
    Goodwill
    Intangibles
    Total Assets$45.95M$295.74M$358.46M
    LiabilitiesTotal Current Liabilities$32.97M$37.98M$50.37M
    Short-Term Debt
    Long-Term Debt$42.54M$41.10M$42.65M
    Long-Term Leases$2.63M$3.03M$4.11M
    Total Liabilities$78.22M$90.34M$98.81M
    EquityCommon Stock & APIC$19.91M$51.35M$58.38M
    Retained Earnings-$406.44M-$520.25M-$651.86M
    Total Equity-$209.38M$205.41M$259.66M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY24FY25FY26
    ActivitiesCash from Operating-$72.23M-$77.61M-$81.70M
    Cash from Investing-$12.23M-$23.31M-$203.28M
    Cash from Financing$77.72M$330.26M$147.09M
    SummaryCapital Expenditure-$12.23M-$22.94M-$34.89M
    Free Cash Flow-$84.46M-$100.54M-$116.59M
    FCF Margin-303.7%-168.1%-122.6%